Bookmark


  • Page views 38
  • PDF Downloads 72


ISSN: 2766-2276
Medicine Group 2025 March 31;6(3):309-311. doi: 10.37871/jbres2085.

 |   |   | 


open access journal Mini Review

Perspectives on an Integrated Approach to Cancer Management

Dana Flavin*

Institute of Integrated Systemic Therapies, 00181 Rome
*Corresponding authors: Dana Flavin, Institute of Integrated Systemic Therapies, 00181 Rome, Italy E-mail:

Received: 03 March 2025 | Accepted: 29 March 2025 | Published: 31 March 2025
How to cite this article: Flavin D. Perspectives on an Integrated Approach to Cancer Management. J Biomed Res Environ Sci. 2025 Mar 31; 6(3): 309-311. doi: 10.37871/jbres2085, Article ID: jbres1757
Copyright:© 2025 Flavin D. Distributed under Creative Commons CC-BY 4.0.

While conventional treatments remain central to cancer care, emerging evidence suggests that complementary strategies may modulate tumor progression. This paper outlines an integrated approach that includes detoxification, exercise, nutritional modifications, immune system support, and the use of certain natural compounds. Although preliminary data are promising, further rigorous studies are needed to validate these interventions.

Cancer is a multifaceted disease influenced by genetic, environmental, and lifestyle factors. Recent decades of research have explored various complementary interventions that might help the body combat tumor growth. This manuscript presents an integrated perspective by discussing methods that target multiple pathways involved in cancer progression

Cancer cells are known to accumulate various toxins, including heavy metals, bacteria, viruses, and other harmful agents that may interfere with mitochondrial function and normal DNA repair processes [1]. Some protocols advocate for metal detoxification to help restore cellular balance; however, robust clinical evidence is required to support these claims fully [2]. This is why for example a metal detox is imperative as the metals destroy the healthy frequencies coming from the mitochondria and cause DNA to continue to replicate. Exercise reduces the blood Vessel Growth to Tumors (VEGF) and helps to sweat off toxins in the body [3].

Exercise also helps the mood and that too is important. Regular physical activity may reduce tumor vascularization by lowering the expression of vascular endothelial growth factor (VEGF), a key mediator of blood vessel growth in tumors [4]. In addition, exercise can enhance toxin elimination through increased sweating and improve mood, which may help mitigate stress-related pathways implicated in tumor progression [5]. It is important to note that while these associations are promising, more controlled studies are needed to clarify the underlying mechanisms.

Our diet is very important as many substances in food can stimulate tumor growth, including sugar, white flour, cow’s milk products, red meat and even chicken and turkey [6,7]. Some of these are methionine containing foods. Methionine feeds tumors. The wrong foods change the pH and create acidity in and around tumors [8]. Even the bacteria in our GI tract can go to a tumor and feed it methionine. That is why the good bacteria must be supported. For example, foods high in methionine might promote tumor growth [9]. Conversely, fermented foods such as sauerkraut and kimchi support beneficial gut bacteria, which could influence cancer cell metabolism and overall health [10]. More research is required to determine the exact role of specific dietary components in cancer progression. Sauerkraut, kimchi and other cabbage fermented foods are excellent for this as well as medications like ivermectin [11,12]. They raise the baceriatoides good bacteria and lower the fumicutes, the bad bacteria that feed tumor cells.

Some evidence suggests that parasites may compromise immune function, reducing the body’s ability to target cancer cells effectively [13]. Compounds such as fenbendazole and mebendazole have been proposed to not only act as antiparasitics but also to interfere with nutrient uptake in tumor cells (e.g., blocking glutamine and glucose receptors) [14]. Additionally, Low-Dose Naltrexone (LDN) has been explored for its potential to reduce immune suppression by lowering T suppressor cell activity, thereby enhancing the body's anticancer responses [15]. These approaches remain experimental and warrant further investigation. Sometimes we add dichloracetate to block the anaerobic metabolism in cancers and prevent the cells from dividing. We keep patients away from EMF and negative magnetic fields.

Interventions like Dichloroacetate (DCA) have been studied for their potential to inhibit the anaerobic metabolism characteristic of many cancers, which might slow tumor cell proliferation [16]. Environmental factors, including exposure to Electromagnetic Fields (EMF), are also considered; minimizing exposure alongside ensuring high-quality water consumption may contribute to overall patient wellness [17]. Furthermore, natural compounds—such as oregano oil, dandelion root, and red sage (Danshen)—are being examined for their potential to modulate cellular signaling pathways in cancer [18]. While these findings are intriguing, they should be interpreted with caution until confirmed by larger clinical studies. One herb, Dandelion root is excellent to help in many cancers as is red sage, or Danshen, from China, that repairs the mRNA in tumor cells [19].

As one sees this is not rocket science but it is pure science from decades of reading and testing until we can now say, Cancer is reversible…….. and WE KNOW HOW!!!

The integrated strategies discussed herein illustrate a multi-targeted approach that may support conventional cancer therapies. Although the notion that “cancer is reversible” is an overstatement, there is growing evidence that complementary interventions can influence the course of the disease. It is crucial that these approaches be subjected to rigorous scientific evaluation before they are adopted as standard clinical practice.

  1. Singh V, Singh N, Verma M, Kamal R, Tiwari R, Sanjay Chivate M, Rai SN, Kumar A, Singh A, Singh MP, Vamanu E, Mishra V. Hexavalent-Chromium-Induced Oxidative Stress and the Protective Role of Antioxidants against Cellular Toxicity. Antioxidants (Basel). 2022 Nov 30;11(12):2375. doi: 10.3390/antiox11122375. PMID: 36552581; PMCID: PMC9774749.
  2. Watson B. The detox strategy: vibrant health in 5 easy steps. Simon and Schuster: 2009.
  3. Schmidinger M. Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors. EJC Suppl. 2013 Sep;11(2):172-91. doi: 10.1016/j.ejcsup.2013.07.016. PMID: 26217127; PMCID: PMC4041401.
  4. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69 Suppl 3:4-10. doi: 10.1159/000088478. Epub 2005 Nov 21. PMID: 16301830.
  5. Dhama K, Latheef SK, Dadar M, Samad HA, Munjal A, Khandia R, Karthik K, Tiwari R, Yatoo MI, Bhatt P, Chakraborty S, Singh KP, Iqbal HMN, Chaicumpa W, Joshi SK. Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Front Mol Biosci. 2019 Oct 18;6:91. doi: 10.3389/fmolb.2019.00091. PMID: 31750312; PMCID: PMC6843074.
  6. White EG, White J. Counsels on diet and foods. 1946.
  7. Mosby TT, Cosgrove M, Sarkardei S, Platt KL, Kaina B. Nutrition in adult and childhood cancer: role of carcinogens and anti-carcinogens. Anticancer Res. 2012 Oct;32(10):4171-92. PMID: 23060538.
  8. Gao X, Sanderson SM, Dai Z, Reid MA, Cooper DE, Lu M, Richie JP Jr, Ciccarella A, Calcagnotto A, Mikhael PG, Mentch SJ, Liu J, Ables G, Kirsch DG, Hsu DS, Nichenametla SN, Locasale JW. Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature. 2019 Aug;572(7769):397-401. doi: 10.1038/s41586-019-1437-3. Epub 2019 Jul 31. PMID: 31367041; PMCID: PMC6951023.
  9. Cavuoto P, Fenech MF. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat Rev. 2012 Oct;38(6):726-36. doi: 10.1016/j.ctrv.2012.01.004. Epub 2012 Feb 17. PMID: 22342103.
  10. Stiemsma LT, Nakamura RE, Nguyen JG, Michels KB. Does Consumption of Fermented Foods Modify the Human Gut Microbiota? J Nutr. 2020 Jul 1;150(7):1680-1692. doi: 10.1093/jn/nxaa077. PMID: 32232406; PMCID: PMC7330458.
  11. Jana U. Wonder Probiotics Foods. Chapter 05.
  12. Fijan S, Fijan P, Wei L, Marco ML. Health benefits of kimchi, sauerkraut, and other fermented foods of the genus brassica. Applied Microbiology. 2024;4(3):1165-1176.
  13. Sajid MS, Iqbal Z, Muhammad G, Iqbal MU. Immunomodulatory effect of various anti-parasitics: a review. Parasitology. 2006 Mar;132(Pt 3):301-13. doi: 10.1017/S0031182005009108. Epub 2005 Dec 7. PMID: 16332285.
  14. Mukherjee S, Mukherjee N, Gayen P, Roy P, Babu SP. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives. Curr Drug Metab. 2016;17(10):937-970. doi: 10.2174/1389200217666161004143152. PMID: 27719626.
  15. Ciwun M, Tankiewicz-Kwedlo A, Pawlak D. Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy. Cancers (Basel). 2024 Mar 21;16(6):1240. doi: 10.3390/cancers16061240. PMID: 38539570; PMCID: PMC10968813.
  16. Dunbar EM, Coats BS, Shroads AL, Langaee T, Lew A, Forder JR, Shuster JJ, Wagner DA, Stacpoole PW. Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors. Invest New Drugs. 2014 Jun;32(3):452-64. doi: 10.1007/s10637-013-0047-4. Epub 2013 Dec 3. PMID: 24297161; PMCID: PMC4455946.
  17. Belyaev I, Dean A, Eger H, Hubmann G, Jandrisovits R, Kern M, Kundi M, Moshammer H, Lercher P, Müller K, Oberfeld G, Ohnsorge P, Pelzmann P, Scheingraber C, Thill R. EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses. Rev Environ Health. 2016 Sep 1;31(3):363-97. doi: 10.1515/reveh-2016-0011. PMID: 27454111.
  18. Hassan HA, El-Gharib NE, Azhari AF. Role of natural antioxidants in the therapeutic management of hepatocellular carcinoma. Hepatoma Research. 2016;2:216-223.
  19. Zhou M, Yue Y, Wang Y, Yan S. Polysaccharides from Chinese herbs as natural weapons against colorectal cancer. Biosci Rep. 2023 May 31;43(5):BSR20230041. doi: 10.1042/BSR20230041. PMID: 36951135; PMCID: PMC10196152.

✨ Call for Preprints Submissions

Are you the author of a recent Preprint? We invite you to submit your manuscript for peer-reviewed publication in our open access journal.
Benefit from fast review, global visibility, and exclusive APC discounts.

Submit Now   Archive
?